Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Faslodex (Fulvestrant) Injection
Company:  AstraZeneca Pharmaceuticals
Application No.:  21-344
Approval Date: 4/25/2002


Date created: June 25, 2002

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.